NASDAQ:GRTS

Gritstone Oncology News Headlines

$8.85
+0.23 (+2.67 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.60
Now: $8.85
$9.61
50-Day Range
$8.62
MA: $12.35
$15.75
52-Week Range
$2.54
Now: $8.85
$35.20
Volume1.38 million shs
Average Volume3.16 million shs
Market Capitalization$433.23 million
P/E RatioN/A
Dividend YieldN/A
Beta1.2

Headlines

Gritstone Oncology (NASDAQ GRTS) News Headlines Today

SourceHeadline
Bay Area drug company begins Phase I trial of second-generation Covid vaccineBay Area drug company begins Phase I trial of 'second-generation' Covid vaccine
bizjournals.com - March 29 at 8:01 PM
Gritstone Oncology (NASDAQ:GRTS)  Shares Down 7.8% Gritstone Oncology (NASDAQ:GRTS) Shares Down 7.8%
americanbankingnews.com - March 29 at 2:37 PM
What Type Of Shareholders Own The Most Number of Gritstone Oncology, Inc. (NASDAQ:GRTS) Shares?What Type Of Shareholders Own The Most Number of Gritstone Oncology, Inc. (NASDAQ:GRTS) Shares?
finance.yahoo.com - March 29 at 10:00 AM
Gritstone Announces First Person Dosed with its Second-Generation COVID-19 Vaccine in Phase 1 Study Conducted and Supported by NIAID/IDCRCGritstone Announces First Person Dosed with its Second-Generation COVID-19 Vaccine in Phase 1 Study Conducted and Supported by NIAID/IDCRC
finance.yahoo.com - March 29 at 10:00 AM
Gritstone Oncology (NASDAQ:GRTS) Shares Gap Up to $11.73Gritstone Oncology (NASDAQ:GRTS) Shares Gap Up to $11.73
americanbankingnews.com - March 25 at 10:54 AM
Gritstone Oncology, Inc. (GRTS) Reports Q4 Loss, Tops Revenue EstimatesGritstone Oncology, Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates
nasdaq.com - March 11 at 2:22 PM
Gritstone Reports Fourth Quarter and Full Year 2020 Financial Results and Business HighlightsGritstone Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
finance.yahoo.com - March 11 at 9:22 AM
Gritstone Announces Promotions Within its Leadership TeamGritstone Announces Promotions Within its Leadership Team
finance.yahoo.com - March 8 at 9:29 AM
3 Things to Consider Before You Buy Coronavirus Vaccine Stocks3 Things to Consider Before You Buy Coronavirus Vaccine Stocks
nasdaq.com - March 7 at 1:02 PM
Gritstone Oncology, Inc. (GRTS) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseGritstone Oncology, Inc. (GRTS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - March 3 at 3:04 PM
Gritstone to Present at the H.C. Wainwright Global Life Sciences ConferenceGritstone to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 8:23 AM
Moving Average Crossover Alert: Gritstone Oncology (GRTS)Moving Average Crossover Alert: Gritstone Oncology (GRTS)
finance.yahoo.com - January 27 at 1:25 PM
Is This Under-the-Radar COVID Stock the Next Moderna?Is This Under-the-Radar COVID Stock the Next Moderna?
finance.yahoo.com - January 23 at 10:41 AM
Trade Carefully With Soaring Gritstone OncologyTrade Carefully With Soaring Gritstone Oncology
finance.yahoo.com - January 21 at 10:30 AM
Gritstone’s Unique Approach Can Set Its 2nd Gen COVID-19 Vaccine Apart, Says AnalystGritstone’s Unique Approach Can Set Its 2nd Gen COVID-19 Vaccine Apart, Says Analyst
finance.yahoo.com - January 21 at 12:11 AM
Gritstone Touches Record, Defying Analyst’s Double DowngradeGritstone Touches Record, Defying Analyst’s Double Downgrade
finance.yahoo.com - January 20 at 7:11 PM
Gritstone and Genevant Sciences Announce License Agreement for COVID-19 VaccineGritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine
markets.businessinsider.com - January 20 at 2:10 PM
Why Gritstone Oncologys Stock is Trading Higher TodayWhy Gritstone Oncology's Stock is Trading Higher Today
msn.com - January 20 at 2:10 PM
Biotech Stock Roundup: ALXN Pauses Study, ACRS & GRTS Surge, & Other UpdatesBiotech Stock Roundup: ALXN Pauses Study, ACRS & GRTS Surge, & Other Updates
finance.yahoo.com - January 20 at 2:10 PM
How an East Bay biotech is applying its cancer know-how to a next-generation Covid vaccineHow an East Bay biotech is applying its cancer know-how to a next-generation Covid vaccine
bizjournals.com - January 19 at 8:59 PM
Will Gritstones COVID-19 Vaccine Be the Best One Yet?Will Gritstone's COVID-19 Vaccine Be the Best One Yet?
msn.com - January 19 at 3:59 PM
Why Gritstone Oncology Is Bolting Higher TodayWhy Gritstone Oncology Is Bolting Higher Today
msn.com - January 19 at 3:59 PM
Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2
finance.yahoo.com - January 19 at 3:59 PM
Gritstone Soars Due to Progress on COVID VaccineGritstone Soars Due to Progress on COVID Vaccine
finance.yahoo.com - January 19 at 3:59 PM
Gritstone Oncology to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGritstone Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 11 at 10:16 AM
Gritstone Oncology Announces Private Placement Financings Totaling $125 MillionGritstone Oncology Announces Private Placement Financings Totaling $125 Million
finance.yahoo.com - December 28 at 9:29 AM
Gritstone Oncology Announces $110 Million Private PlacementGritstone Oncology Announces $110 Million Private Placement
finance.yahoo.com - December 23 at 11:36 AM
News for Gritstone Oncology Inc Registered ShsNews for Gritstone Oncology Inc Registered Shs
markets.businessinsider.com - November 20 at 11:10 PM
Gritstone Oncology Reports Third Quarter Financial Results and Recent HighlightsGritstone Oncology Reports Third Quarter Financial Results and Recent Highlights
finance.yahoo.com - November 5 at 9:54 AM
Dosing underway in Gritstone Oncologys two neoantigen immunotherapiesDosing underway in Gritstone Oncology's two neoantigen immunotherapies
seekingalpha.com - November 2 at 1:34 PM
Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE and its Off-the-Shelf Neoantigen Immunotherapy SLATEGritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE and its Off-the-Shelf Neoantigen Immunotherapy SLATE
finance.yahoo.com - November 2 at 8:33 AM
Can Gritstone Oncology (NASDAQ:GRTS) Afford To Invest In Growth?Can Gritstone Oncology (NASDAQ:GRTS) Afford To Invest In Growth?
finance.yahoo.com - September 21 at 1:41 PM
Gritstone Oncology Announces Updated Presentation Time at Cantor Virtual Global Healthcare ConferenceGritstone Oncology Announces Updated Presentation Time at Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 15 at 11:15 AM
Gritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in SeptemberGritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in September
finance.yahoo.com - September 8 at 12:38 PM
Oncology Stocks Are Trading Materially Lower The Last 2 MonthsOncology Stocks Are Trading Materially Lower The Last 2 Months
seekingalpha.com - August 24 at 1:58 PM
Oncology Stocks Area Trading Materially Lower The Last 2 MonthsOncology Stocks Area Trading Materially Lower The Last 2 Months
seekingalpha.com - August 24 at 8:58 AM
3 “Strong Buy” Healthcare Stocks Under $5 That Could See Outsized Gains3 “Strong Buy” Healthcare Stocks Under $5 That Could See Outsized Gains
finance.yahoo.com - August 6 at 6:07 PM
Gritstone Oncology, Inc. (GRTS) Reports Q2 Loss, Misses Revenue EstimatesGritstone Oncology, Inc. (GRTS) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 5 at 3:48 PM
Gritstone Oncology EPS beats by $0.02, misses on revenueGritstone Oncology EPS beats by $0.02, misses on revenue
seekingalpha.com - August 5 at 10:46 AM
Gritstone Oncology Reports Second Quarter Financial Results and Recent HighlightsGritstone Oncology Reports Second Quarter Financial Results and Recent Highlights
finance.yahoo.com - August 5 at 10:46 AM
Analysts Estimate Gritstone Oncology, Inc. (GRTS) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Gritstone Oncology, Inc. (GRTS) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - August 3 at 1:57 PM
Gritstone Oncology to Present at Two Upcoming Investor Conferences in AugustGritstone Oncology to Present at Two Upcoming Investor Conferences in August
finance.yahoo.com - August 3 at 8:29 AM
Gritstone Oncology, Inc. (2JQ.F)Gritstone Oncology, Inc. (2JQ.F)
in.finance.yahoo.com - July 30 at 7:32 PM
Do Institutions Own Gritstone Oncology, Inc. (NASDAQ:GRTS) Shares?Do Institutions Own Gritstone Oncology, Inc. (NASDAQ:GRTS) Shares?
finance.yahoo.com - July 22 at 2:57 PM
Despite The Fall Gritstone Oncology Phase 1 Results Reveal The Efficacy Signal Ive Been Looking ForDespite The Fall Gritstone Oncology Phase 1 Results Reveal The Efficacy Signal I've Been Looking For
seekingalpha.com - July 21 at 12:31 PM
Gritstone Oncology down 32% on cancer vaccine dataGritstone Oncology down 32% on cancer vaccine data
seekingalpha.com - July 13 at 9:38 AM
Gritstone Oncology to Present Clinical Data from Ongoing GRANITE and SLATE Phase 1 Studies During Investor Webcast on July 13Gritstone Oncology to Present Clinical Data from Ongoing GRANITE and SLATE Phase 1 Studies During Investor Webcast on July 13
finance.yahoo.com - June 24 at 8:15 AM
Gritstone Oncology Announces the Addition of Jean-Charles Soria, M.D., Ph.D., to its Scientific Advisory BoardGritstone Oncology Announces the Addition of Jean-Charles Soria, M.D., Ph.D., to its Scientific Advisory Board
finance.yahoo.com - June 10 at 9:36 AM
Gritstone Oncology (GRTS): Strong Industry, Solid Earnings Estimate RevisionsGritstone Oncology (GRTS): Strong Industry, Solid Earnings Estimate Revisions
finance.yahoo.com - May 22 at 1:13 PM
Analysts Have Made A Financial Statement On Gritstone Oncology, Inc.s (NASDAQ:GRTS) First-Quarter ReportAnalysts Have Made A Financial Statement On Gritstone Oncology, Inc.'s (NASDAQ:GRTS) First-Quarter Report
finance.yahoo.com - May 10 at 2:45 PM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.